Prosecution Insights
Prosecution Insights
5 pending office actions • 4 art units • 5 examiners • 0 of 5 (0%) have an AI response strategy ready • 5 patents granted in the last 365 days
Based on the USPTO statutory response window for each pending office action. 4 of the docket's apps have a known mailing date; the rest are excluded from the tile counts.
Every pending office action with a known statutory deadline, placed on a days-until-due axis. Dots left of Today are overdue; the further right, the more runway. Cases that share a deadline window stack vertically. 4 of the docket's apps have a known mailing date.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| §101 + other | 1 (20%) |
| §103 only | 2 (40%) |
| Multi-statute (no §101) | 2 (40%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| MIANO, JOSEPH PAUL | 1 | 36.1% | +64.0% |
| DIVIESTI, KARLA ISOBEL | 1 | 4.2% | +25.0% |
| TAKENAKA, RISA | 1 | 28.6% | +100.0% |
| MOLOYE, TITILAYO | 1 | 63.1% | +47.1% |
| ESPERON, NATHAN GREGORY | 1 | 40.7% | +24.0% |
Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 4 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 17558243 | APPARATUSES AND SYSTEMS FOR PREPARING A MEAT PRODUCT | ESPERON, NATHAN GREGORY | 44d overdue |
| 18069768 | SCALING UP MYOGENIC TISSUE: LATE PASSAGE MYOGENICITY | TAKENAKA, RISA | 7d |
| 18060322 | SUBSTRATES AND BIOREACTORS FOR PREPARING A COMESTIBLE MEAT PRODUCT | MOLOYE, TITILAYO | 33d |
| 18334250 | SUSPENSION BASED CHICKEN PRODUCT FORMULATION | DIVIESTI, KARLA ISOBEL | — |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 5 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 17558243 | APPARATUSES AND SYSTEMS FOR PREPARING A MEAT PRODUCT | ESPERON, NATHAN GREGORY | 44d overdue |
| 18069768 | SCALING UP MYOGENIC TISSUE: LATE PASSAGE MYOGENICITY | TAKENAKA, RISA | 7d |
| 19300583 | HEAT SHOCK INDUCIBLE CELLS AND THEIR MANUFACTURE AND USE | MIANO, JOSEPH PAUL | 29d |
| 18060322 | SUBSTRATES AND BIOREACTORS FOR PREPARING A COMESTIBLE MEAT PRODUCT | MOLOYE, TITILAYO | 33d |
| 18334250 | SUSPENSION BASED CHICKEN PRODUCT FORMULATION | DIVIESTI, KARLA ISOBEL | — |
| Art Unit | Apps |
|---|---|
| 1632 | 2 |
| 1631 | 1 |
| 1792 | 1 |
| 1799 | 1 |
| App # | Title | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|
| 19300583 | HEAT SHOCK INDUCIBLE CELLS AND THEIR MANUFACTURE AND USE | MIANO, JOSEPH PAUL | 1631 | §103 | Final Rejection | 29d | Pending | Aug 14, 2025 |
| 18334250 | SUSPENSION BASED CHICKEN PRODUCT FORMULATION | DIVIESTI, KARLA ISOBEL | 1792 | §103 | Final Rejection | — | Pending | Jun 13, 2023 |
| 18069768 | SCALING UP MYOGENIC TISSUE: LATE PASSAGE MYOGENICITY | TAKENAKA, RISA | 1632 | §101§102§103§112Other | Non-Final OA | 7d | Pending | Dec 21, 2022 |
| 18060322 | SUBSTRATES AND BIOREACTORS FOR PREPARING A COMESTIBLE MEAT PRODUCT | MOLOYE, TITILAYO | 1632 | §102§103§112Other | Non-Final OA | 33d | Pending | Nov 30, 2022 |
| 17558243 | APPARATUSES AND SYSTEMS FOR PREPARING A MEAT PRODUCT | ESPERON, NATHAN GREGORY | 1799 | §103§112Other | Non-Final OA | 44d overdue | Pending | Dec 21, 2021 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free Trial